Nuvelo (Nasdaq: NUVO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo (Nasdaq: NUVO)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edscharp who wrote (89)	1/20/2000 7:17:00 PM
From: Richaaard	Read Replies (1) of 286

I noticed the same comparison a couple days ago. Still if you compare the two companies it looks like HYSQ should be worth more. If AFFX is worth $230, then HYSQ could easily add another 50 points to their value. Although AFFX has all their ducks in a row, someone will want to make a run at them at some point. I don't think HYSQ can go it alone buy I'm betting that they will be part of the equation.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next